Alpha Healthcare Acquisition Corp. III (ALPAW)

Alpha Healthcare Acquisition Corp. III (ALPAW) Financial Services Profile

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) seeking to identify and merge with an existing operating business. As a shell company in the financial services sector, it offers a streamlined path for private companies to access public markets, though its profitability remains a challenge.

What Is the Investment Thesis for ALPAW?

Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to identify and merge with a promising operating company. The potential upside hinges on the target company's future performance and the market's perception of the combined entity. Key value drivers include the management team's expertise in deal-making and the attractiveness of the target company's business model. The company's gross margin is 59.3%. Upcoming catalysts include the announcement of a definitive merger agreement and the subsequent closing of the business combination. Potential risks include the failure to identify a suitable target, regulatory hurdles, and market volatility impacting the valuation of the combined entity. Investors should carefully consider the speculative nature of this investment and the potential for significant losses.

Based on FMP financials and quantitative analysis

ALPAW Key Highlights

• P/E ratio of 3.70, reflecting investor expectations of future earnings potential following a business combination.
• Gross Margin of 59.3%, indicating the potential profitability of the target company's operations after a merger.
• Negative Profit Margin of -199.6% due to minimal operational activity as a shell company.
• No dividend yield, as the company is focused on identifying and completing a business combination rather than distributing profits.
• Operating as a Special Purpose Acquisition Company (SPAC), providing a streamlined path for private companies to access public markets.

Who Are ALPAW's Competitors?

ALPAW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ALPAW's Key Strengths?

• Experienced management team.
• Access to public market capital.
• Flexibility to target various industries.
• Potential for high returns if a successful merger is completed.

What Are ALPAW's Weaknesses?

• No operating history or revenue generation.
• Dependence on identifying and completing a suitable business combination.
• Competition from other SPACs.
• Potential for dilution if additional capital is needed.

What Could Drive ALPAW Stock Higher?

• Announcement of a definitive merger agreement with a target company.
• Completion of the business combination and public listing of the combined entity.
• Positive market sentiment towards SPACs and mergers and acquisitions.
• Successful execution of the target company's growth strategy.
• Realization of synergies and cost savings from the merger.

What Are the Key Risks for ALPAW?

• Failure to identify a suitable target company within the specified timeframe.
• Regulatory hurdles or delays in completing the business combination.
• Market volatility impacting the valuation of the combined entity.
• Competition from other SPACs driving up acquisition prices.
• Dependence on the target company's future performance.

What Are the Growth Opportunities for ALPAW?

• Successful Merger Completion: Alpha Healthcare Acquisition Corp. III's primary growth opportunity lies in successfully identifying and completing a merger with a high-growth potential company. The target company's industry, market position, and financial performance will be critical factors in driving future growth. The timeline for this opportunity is dependent on the company's ability to identify and negotiate a deal, with a typical timeframe of 12-24 months from its initial public offering. The market size will vary depending on the target company's industry, but the potential for significant returns exists if the merger is well-received by investors.
• Strategic Target Selection: The selection of a strategic target company with strong growth prospects and a defensible market position is crucial for Alpha Healthcare Acquisition Corp. III's long-term success. By focusing on companies with innovative technologies, disruptive business models, or significant market opportunities, the company can enhance its potential for value creation. The timeline for this opportunity is ongoing, as the company continuously evaluates potential targets. The market size will depend on the target company's industry, but the potential for significant returns exists if the target company is well-positioned for growth.
• Operational Improvements Post-Merger: After completing a merger, Alpha Healthcare Acquisition Corp. III can drive growth by implementing operational improvements within the target company. This may include streamlining processes, reducing costs, expanding into new markets, or launching new products or services. The timeline for this opportunity is ongoing, as the company continuously seeks to optimize the target company's operations. The market size will depend on the target company's industry, but the potential for significant value creation exists if the company can successfully improve the target company's performance.
• Capital Deployment and Follow-On Investments: Alpha Healthcare Acquisition Corp. III can leverage its access to capital to support the target company's growth initiatives. This may include funding research and development, expanding sales and marketing efforts, or acquiring complementary businesses. The timeline for this opportunity is ongoing, as the company continuously evaluates opportunities to deploy capital and generate returns. The market size will depend on the target company's industry, but the potential for significant value creation exists if the company can effectively deploy capital and drive growth.
• Enhanced Investor Relations and Market Awareness: By effectively communicating its strategy and progress to investors, Alpha Healthcare Acquisition Corp. III can enhance its market awareness and attract a broader investor base. This may include participating in industry conferences, hosting investor presentations, and issuing press releases. The timeline for this opportunity is ongoing, as the company continuously seeks to improve its investor relations efforts. The market size will depend on the company's ability to attract new investors, but the potential for increased valuation and liquidity exists if the company can effectively communicate its value proposition.

What Opportunities Does ALPAW Have?

• Growing demand for SPACs as an alternative to traditional IPOs.
• Availability of attractive target companies in various sectors.
• Potential to create value through operational improvements and strategic acquisitions.
• Favorable market conditions for mergers and acquisitions.

What Threats Does ALPAW Face?

• Increased regulatory scrutiny of SPACs.
• Market volatility impacting the valuation of the combined entity.
• Failure to identify a suitable target company.
• Competition from other SPACs driving up acquisition prices.

What Are ALPAW's Competitive Advantages?

• Experienced management team with a track record of successful deal-making.
• Access to capital through the public markets.
• Flexibility to pursue business combinations across various sectors.
• Potential to create value through operational improvements and strategic acquisitions.

What Does ALPAW Do?

Alpha Healthcare Acquisition Corp. III is a blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. These companies, also known as SPACs (Special Purpose Acquisition Companies), are designed to allow public market investors to participate in private equity-style investments. Alpha Healthcare Acquisition Corp. III does not have any specific business combination under consideration and has not (nor has anyone on its behalf) initiated any substantive discussions, directly or indirectly, with any business combination target. The company's strategy is to identify and complete a business combination with a company that can benefit from being publicly listed. The company was founded to take advantage of opportunities in the healthcare industry, but it is not limited to this sector. The company's success depends on its ability to identify and complete a suitable business combination within a specific timeframe, typically two years from its initial public offering. If the company fails to complete a business combination within this timeframe, it will be forced to liquidate and return the funds to its investors. As of now, the company has not yet identified a target company for acquisition. The company's negative profit margin of -199.6% reflects its current status as a shell company with minimal operational activity, primarily focused on identifying and evaluating potential merger targets.

What Products and Services Does ALPAW Offer?

• Identifies potential target companies for a business combination.
• Conducts due diligence on potential target companies.
• Negotiates merger agreements with target companies.
• Raises capital to fund the business combination.
• Completes the business combination, bringing the target company public.
• Provides ongoing support and guidance to the target company.
• Seeks to create value for shareholders through the business combination.

How Does ALPAW Make Money?

• Raises capital through an initial public offering (IPO).
• Uses the capital to identify and merge with a private company.
• Generates returns for investors through the appreciation of the combined company's stock.
• The management team typically receives equity in the combined company as compensation.

What Industry Does ALPAW Operate In?

Alpha Healthcare Acquisition Corp. III operates within the SPAC market, a segment of the financial services industry characterized by intense competition and regulatory scrutiny. SPACs have gained popularity as an alternative to traditional IPOs, offering private companies a faster and more efficient route to public listing. The industry is subject to market trends, including investor sentiment towards SPACs and the availability of attractive target companies. The competitive landscape includes numerous other SPACs seeking to identify and merge with promising businesses across various sectors. The success of Alpha Healthcare Acquisition Corp. III depends on its ability to differentiate itself from competitors and secure a high-quality target company.

Who Are ALPAW's Key Customers?

• Institutional investors seeking access to private equity-style investments.
• Retail investors interested in participating in high-growth opportunities.
• Private companies seeking a faster and more efficient route to public listing.

ROE 133%Key Financial Metrics

Return on equity for Alpha Healthcare Acquisition Corp. III stands at 133.4%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.15 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -36.7%, the inverse of the P/E and a quick read on earnings relative to price.

Alpha Healthcare Acquisition Corp. III (ALPAW) Valuation Context

Relative to its peer group, ALPAW's quantitative score of 54/100 is roughly in line with the peer average of 63/100.

ALPAW Revenue & Earnings Trend

In Q1 2026, ALPAW generated $392K in top-line revenue, marking a sequential decrease of 17.2%. The company recorded a net loss of $1.4M, with diluted EPS of $-0.75. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Financial Services. Across the four most recent quarters, ALPAW averaged $-1.38 in diluted EPS.

Net buyingInsider Activity

The most recent 12 insider filings for Alpha Healthcare Acquisition Corp. III break down as 0 sales and 12 purchases. On net that is roughly 10K shares acquired (about $38K) — insiders putting money in tends to read as conviction.

ALPAW Financials

ALPAW Latest News

No recent news available for ALPAW.

ALPAW Analyst Consensus

ALPAW MoonshotScore

Alpha Healthcare Acquisition Corp. III Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources